DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors

VANCOUVER, British Columbia and MENLO PARK, Calif., June 25, 2018 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developm... Biopharmaceuticals, Personnel DelMar Pharmaceuticals, angiogenesis, VEGF
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news